KaiBioTech Co., Ltd. engages in the development and manufacture of radiopharmaceuticals, medical devices, dementia agents, and liver therapeutics. Its products include 18F Florbetaven, FDG injection, Lu-177 DGUL, and Micro-CHI. The company was founded on December 18, 2012 and is headquartered in Jeonju-si, South Korea.